The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Tunable and reversible drug control of protein production via a self-excising degron
Open accessAbstract
An effective method for direct chemical control over the production of specific proteins would be widely useful. We describe small molecule-assisted shutoff (SMASh), a technique in which proteins are fused to a degron that removes itself in the absence of drug, resulting in the production of an untagged protein. Clinically tested HCV protease inhibitors can then block degron removal, inducing rapid degradation of subsequently synthesized copies of the protein. SMASh allows reversible and dose-dependent shutoff of various proteins in multiple mammalian cell types and in yeast. We also used SMASh to confer drug responsiveness onto an RNA virus for which no licensed inhibitors exist. As SMASh does not require the permanent fusion of a large domain, it should be useful when control over protein production with minimal structural modification is desired. Furthermore, as SMASh involves only a single genetic modification and does not rely on modulating protein-protein interactions, it should be easy to generalize to multiple biological contexts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, AP1867-derivative PROTACs can mediate the selective degradation of heterologous FKBP12F36V-tagged proteins, enforcing rapid and potent depletion in vitro and in vivo200,201.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [200]
In the citing paper
“In addition, Nabet and colleagues200,201 have developed the dTag system that uses PROTACs composed of a CRBN or VHL ligand, a linker and an AP1867 derivative.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [200]
In the citing paper
“Fusion of a SMASh-tag to either terminus of target proteins exhibits a degron-like function, and protein stability is tuneable with asunaprevir doses ranging from 0.15 nM (slightly reduced levels) to 1.5 µM (undetectable).”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [34]
In the citing paper
“No adverse effects on cell growth induced by asunaprevir were reported [34].”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [34]
In the citing paper
“Fused to either the N- or C-terminus of a POI, and connected by an NS3 cleavage site, the degron continuously removes itself from the fusion protein, leaving the POI untagged within the cell (Fig. 2c).”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global analysis of protein localization in budding yeast
Huh, W.-K., Falvo, J. V., Gerke, L. C., Carroll, A. S., Howson, R. W., Weissman, J. S., & O'Shea, E. K. (2003) · Nature · doi:10.1038/nature02026 · Cited by 4,248
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
Mumberg, D., Müller, R., & Funk, M. (1995) · Gene · doi:10.1016/0378-1119(95)00037-7 · Cited by 1,972
An auxin-based degron system for the rapid depletion of proteins in nonplant cells
Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T., & Kanemaki, M. (2009) · Nature Methods · doi:10.1038/nmeth.1401 · Cited by 1,663
Elevated recombination rates in transcriptionally active DNA
Thomas, B. J., & Rothstein, R. J. (1989) · Cell · doi:10.1016/0092-8674(89)90584-9 · Cited by 1,603
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Shimobayashi, M., & Hall, M. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3757 · Cited by 1,053
Buchholz, U. J., Finke, S., & Conzelmann, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.251-259.1999 · Cited by 1,036
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Lamarre, D., Anderson, P. C., Bailey, M. D., Beaulieu, P. L., Bolger, G. T., Bonneau, P. R., Bös, M., Cameron, D. R., Cartier, M., Cordingley, M. G., et al. (2003) · Nature · doi:10.1038/nature02099 · Cited by 918
Cited by
Sorted by citations
The dTAG system for immediate and target-specific protein degradation
Nabet, B., Roberts, J. M., Buckley, D. L., Paulk, J., Dastjerdi, S., Yang, A., Leggett, A. L., Erb, M. A., Lawlor, M. A., Souza, A., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0021-8 · Cited by 1,118
Rapid protein depletion in human cells by auxin-inducible degron tagging with short homology donors
Natsume, T., Kiyomitsu, T., Saga, Y., & Kanemaki, M. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.001 · Cited by 673
Epigenetic modifications of histones in cancer
Zhao, Z., & Shilatifard, A. (2019) · Genome biology · doi:10.1186/s13059-019-1870-5 · Cited by 591
Yesbolatova, A., Saito, Y., Kitamoto, N., Makino‐Itou, H., Ajima, R., Nakano, R., Nakaoka, H., Fukui, K., Gamo, K., Tominari, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19532-z · Cited by 544
Programmable protein circuits in living cells
Gao, X. J., Chong, L. S., Kim, M. S., & Elowitz, M. B. (2018) · Science · doi:10.1126/science.aat5062 · Cited by 310
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
Nabet, B., Ferguson, F. M., Seong, B. K. A., Kuljanin, M., Leggett, A. L., Mohardt, M. L., Robichaud, A., Conway, A. S., Buckley, D. L., Mancias, J. D., et al. (2020) · doi:10.1101/2020.03.13.980946 · Cited by 312
Small-Molecule Modulation of Protein Homeostasis
Burslem, G. M., & Crews, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00077 · Cited by 298
Programming gene and engineered-cell therapies with synthetic biology
Kitada, T., DiAndreth, B., Teague, B. P., & Weiss, R. (2018) · Science · doi:10.1126/science.aad1067 · Cited by 285
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
Jan, M., Scarfò, I., Larson, R. C., Walker, A., Schmidts, A., Guirguis, A. A., Gasser, J. A., Slabicki, M. M., Bouffard, A. A., Castaño, A. P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb6295 · Cited by 284
El Khattabi, L., Zhao, H., Kalchschmidt, J., Young, N., Jung, S., Van Blerkom, P., Kieffer-Kwon, P., Kieffer-Kwon, K.-R., Park, S., Wang, X., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.011 · Cited by 244
Evaluating Enhancer Function and Transcription
Field, A. R., & Adelman, K. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011420-095916 · Cited by 227
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
Labanieh, L., Majzner, R. G., Klysz, D. D., Sotillo, E., Fisher, C., Vilches-Moure, J. G., Pacheco, K. Z., Malipatlolla, M. B., Xu, P., Hui, J. H., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.041 · Cited by 232
Self-citationTargeted Protein Degradation by Small Molecules
Bondeson, D. P., & Crews, C. M. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103507 · Cited by 207
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Luh, L. M., Scheib, U., Juenemann, K., Wortmann, L., Brands, M., & Cromm, P. M. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004310 · Cited by 201
Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
Wu, T., Yoon, H., Xiong, Y., Dixon-Clarke, S. E., Nowak, R. P., & Fischer, E. S. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0438-0 · Cited by 186
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
Verma, R., Mohl, D., & Deshaies, R. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.010 · Cited by 185
Multidimensional control of therapeutic human cell function with synthetic gene circuits
Li, H.-S., Israni, D. V., Gagnon, K. A., Gan, K. A., Raymond, M. H., Sander, J. D., Roybal, K. T., Joung, J. K., Wong, W. W., & Khalil, A. S. (2022) · Science · doi:10.1126/science.ade0156 · Cited by 187
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
Jan, M., Sperling, A. S., & Ebert, B. L. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00479-z · Cited by 137
Programmable biomolecular switches for rewiring flux in Escherichia coli
Gao, C., Hou, J., Xu, P., Guo, L., Chen, X., Hu, G., Ye, C., Edwards, H., Chen, J., Chen, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11793-7 · Cited by 134
DNA Replication Determines Timing of Mitosis by Restricting CDK1 and PLK1 Activation
Lemmens, B. B. L. G., Hégarat, N., Akopyan, K., Sala-Gaston, J., Bártek, J., Hochegger, H., & Lindqvist, A. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.026 · Cited by 129
Experimental models and tools to tackle glioblastoma
Robertson, F., Marqués‐Torrejón, M. Á., Morrison, G. M., & Pollard, S. M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.040386 · Cited by 127
Precision Control of CRISPR-Cas9 Using Small Molecules and Light
Gangopadhyay, S. A., Cox, K. J., Manna, D., Lim, D., Maji, B., Zhou, Q., & Choudhary, A. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01202 · Cited by 119
Modulation of chimeric antigen receptor surface expression by a small molecule switch
Juillerat, A., Tkach, D., Busser, B. W., Temburni, S., Valton, J., Duclert, A., Poirot, L., Depil, S., & Duchateau, P. N. (2019) · BMC Biotechnology · doi:10.1186/s12896-019-0537-3 · Cited by 124
High-performance multiplex drug-gated CAR circuits
Li, H.-S., Wong, N. M. L., Tague, E. P., Ngo, J. T., Khalil, A. S., & Wong, W. W. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.008 · Cited by 125
Conditional Degrons for Controlling Protein Expression at the Protein Level
Natsume, T., & Kanemaki, M. T. (2017) · Annual Review of Genetics · doi:10.1146/annurev-genet-120116-024656 · Cited by 114
Advances in targeted degradation of endogenous proteins
Röth, S., Fulcher, L. J., & Sapkota, G. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03112-6 · Cited by 92
Transcription and Beyond: Delineating FOXG1 Function in Cortical Development and Disorders
Hou, P., hAilín, D. Ó., Vogel, T., & Hanashima, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00035 · Cited by 82
Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
Wagner, T. E., Becraft, J. R., Bodner, K., Teague, B. P., Zhang, X., Woo, A. R. E., Porter, E. B., Alburquerque, B., Dobosh, B. S., Andries, O., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0146-9 · Cited by 83
Richman, S. A., Wang, L.-C., Moon, E. K., Khire, U. R., Albelda, S. Μ., & Milone, M. C. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.004 · Cited by 88
Continuous evolution of compact protein degradation tags regulated by selective molecular glues
Mercer, J. A. M., DeCarlo, S. J., Burman, S. S. R., Sreekanth, V., Nelson, A. T., Hunkeler, M., Chen, P. J., Donovan, K. A., Kokkonda, P., Tiwari, P. K., et al. (2024) · Science · doi:10.1126/science.adk4422 · Cited by 85
Multi-input chemical control of protein dimerization for programming graded cellular responses
Wink, G., Wang, Z., Wei, C. T., Greisen, P. J., Warner, K., Cunningham‐Bryant, D., Park, K., Brunette, T., Sheffler, W., Baker, D. A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0242-8 · Cited by 79
Cella, F., Wróblewska, L., Weiss, R., & Siciliano, V. (2018) · Nature Communications · doi:10.1038/s41467-018-06825-7 · Cited by 78
Cyclin A triggers Mitosis either via the Greatwall kinase pathway or Cyclin B
Hégarat, N., Crncec, A., Rodríguez, M. F. S. P., Iturra, F. E., Gu, Y. H., Busby, O., Lang, P. F., Barr, A. R., Bakal, C., Kanemaki, M. T., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020104419 · Cited by 78
FANCM regulates repair pathway choice at stalled replication forks
Panday, A., Willis, N. A., Elango, R., Menghi, F., Duffey, E. E., Liu, E. T., & Scully, R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.044 · Cited by 75
Safety by design: Biosafety and biosecurity in the age of synthetic genomics
Hoffmann, S. A., Diggans, J., Densmore, D. M., Dai, J., Knight, T., LeProust, E. M., Boeke, J. D., Wheeler, N. E., & Cai, Y. (2023) · iScience · doi:10.1016/j.isci.2023.106165 · Cited by 87
Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics
Teixeira, A. P., & Fussenegger, M. (2023) · Advanced Science · doi:10.1002/advs.202309088 · Cited by 79
Frei, T., Chang, C.-H., Filo, M., Arampatzis, A., & Khammash, M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122132119 · Cited by 72
Programmable C‐to‐U RNA editing using the human APOBEC3A deaminase
Huang, X., Lv, J., Li, Y., Mao, S., Li, Z., Jing, Z., Sun, Y., Zhang, X., Shen, S., Wang, X., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020104741 · Cited by 71
Safe CRISPR: Challenges and Possible Solutions
Pineda, M., Lear, A., Collins, J. P., & Kiani, S. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.09.010 · Cited by 71
A compact synthetic pathway rewires cancer signaling to therapeutic effector release
Chung, H. K., Zou, X., Bajar, B. T., Brand, V. R., Huo, Y., Alcudia, J. F., Ferrell, J. E., & Lin, M. Z. (2019) · Science · doi:10.1126/science.aat6982 · Cited by 69
Self-citationProtein binders and their applications in developmental biology
Harmansa, S., & Affolter, M. (2018) · Development · doi:10.1242/dev.148874 · Cited by 69
ZC3H4 restricts non-coding transcription in human cells
Estell, C., Davidson, L., Steketee, P. C., Monier, A., & West, S. (2021) · eLife · doi:10.7554/elife.67305 · Cited by 67
Pick a Tag and Explore the Functions of Your Pet Protein
Vandemoortele, G., Eyckerman, S., & Gevaert, K. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.03.016 · Cited by 65
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
Huang, J., Huang, X., & Huang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019115 · Cited by 72
Peptidic degron for IMiD-induced degradation of heterologous proteins
Koduri, V., McBrayer, S. K., Liberzon, E., Wang, A. C., Briggs, K. J., Cho, H., & Kaelin, W. G. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818109116 · Cited by 64
Gene Tagging Strategies To Assess Protein Expression, Localization, and Function in Drosophila.
Kanca, O., Bellen, H. J., & Schnorrer, F. (2017) · PubMed Central · doi:10.1534/genetics.117.199968 · Cited by 64
Engineering Next-Generation CAR-T Cells for Better Toxicity Management
Andrea, A. E., Chiron, A., Bessoles, S., & Hacein‐Bey‐Abina, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228620 · Cited by 63
Chemogenetic control of gene expression and cell signaling with antiviral drugs
Tague, E. P., Dotson, H. L., Tunney, S. N., Sloas, D. C., & Ngo, J. T. (2018) · Nature Methods · doi:10.1038/s41592-018-0042-y · Cited by 51
A modular degron library for synthetic circuits in mammalian cells
Chassin, H., Müller, M., Tigges, M., Scheller, L., Lang, M., & Fussenegger, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09974-5 · Cited by 57
Ivanova, A., Badertscher, L., O’Driscoll, G., Bergman, J., Gordon, E., Gunnarsson, A., Johansson, C., Munson, M. J., Spinelli, C., Torstensson, S., et al. (2023) · Advanced Science · doi:10.1002/advs.202304389 · Cited by 55
Safety switches for adoptive cell therapy
Sahillioğlu, A. C., & Schumacher, T. N. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.07.002 · Cited by 57
StaPLs: versatile genetically encoded modules for engineering drug-inducible proteins
Jacobs, C. L., Badiee, R. K., & Lin, M. Z. (2018) · Nature Methods · doi:10.1038/s41592-018-0041-z · Cited by 51
Self-citationSystematic profiling of conditional degron tag technologies for target validation studies
Bondeson, D. P., Mullin-Bernstein, Z., Oliver, S., Skipper, T. A., Atack, T. C., Bick, N. R., Ching, M., Guirguis, A. A., Kwon, J. J., Langan, C. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33246-4 · Cited by 47
Čermáková, K., & Hodges, H. C. (2018) · Molecules · doi:10.3390/molecules23081958 · Cited by 51
Vevea, J., & Chapman, E. R. (2020) · eLife · doi:10.7554/elife.56469 · Cited by 45
Li, C., Jiang, T., Li, M., Zou, Y., & Yan, Y. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107853 · Cited by 46
Sheng, C., Mendler, I.-H., Rieke, S., Snyder, P., Jentsch, M., Friedrich, D., Drossel, B., & Loewer, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.031 · Cited by 45
Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
Zhu, W., Zhang, B., Li, M., Mo, F., Mi, T., Wu, Y., Teng, Z., Zhou, Q., Li, W., & Hu, B. (2019) · Nature Communications · doi:10.1038/s41467-019-08841-7 · Cited by 46
An Inducible System for Rapid Degradation of Specific Cellular Proteins Using Proteasome Adaptors
Wilmington, S. R., & Matouschek, A. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152679 · Cited by 44
On the cutting edge: protease-based methods for sensing and controlling cell biology
Chung, H. K., & Lin, M. Z. (2020) · Nature Methods · doi:10.1038/s41592-020-0891-z · Cited by 43
Self-citationNew directions in chimeric antigen receptor T cell [CAR‐T] therapy and related flow cytometry
Maryamchik, E., Gallagher, K., Preffer, F. I., Kadauke, S., & Maus, M. V. (2020) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21880 · Cited by 43
Mehta, S., Buyanbat, A., Yan, K., Karayel, Ö., Goldman, S. R., Seruggia, D., Zhang, K., Fujiwara, Y., Donovan, K. A., Zhu, Q., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.06.007 · Cited by 42
Yan, D., Weisshaar, M., Lamb, K. M., Chung, H. K., Lin, M. Z., & Plemper, R. K. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00623 · Cited by 39
Self-citationZhang, C., Ötjengerdes, R., Roewe, J., Mejı́as, R., & Marschall, A. L. J. (2020) · BioDrugs · doi:10.1007/s40259-020-00419-w · Cited by 44
Maneiro, M., Vita, E. D., Conole, D., Kounde, C. S., Zhang, Q., & Tate, E. W. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.002 · Cited by 38
Rago, F., DiMare, M. T., Elliott, G., Ruddy, D. A., Sovath, S., Kerr, G., Bhang, H. C., & Jagani, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.009 · Cited by 35
Synthetic Control of Protein Degradation during Cell Proliferation and Developmental Processes
Trauth, J., Scheffer, J., Hasenjäger, S., & Taxis, C. (2019) · ACS Omega · doi:10.1021/acsomega.8b03011 · Cited by 34
Davidson, L., Francis, L. I., Eaton, J. D., & West, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108319 · Cited by 36
Identification and characterization of cancer vulnerabilities via targeted protein degradation
Mayor-Ruiz, C., & Winter, G. E. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2018.12.003 · Cited by 33
A Small Molecule-Controlled Cas9 Repressible System
Wu, Y., Yang, L., Chang, T., KANDEEL, F. R., & Yee, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.026 · Cited by 32
Designed protease-based signaling networks
Fink, T., & Jerala, R. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102146 · Cited by 31
CasTuner is a degron and CRISPR/Cas-based toolkit for analog tuning of endogenous gene expression
Noviello, G., Gjaltema, R. A. F., & Schulz, E. G. (2023) · Nature Communications · doi:10.1038/s41467-023-38909-4 · Cited by 34
A Novel Destabilizing Domain Based on a Small-Molecule Dependent Fluorophore
Navarro, R., Chen, L.-C., Rakhit, R., & Wandless, T. J. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00234 · Cited by 31
CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function
Sahillioğlu, A. C., Toebes, M., Apriamashvili, G., Gomez, R., & Schumacher, T. N. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0095 · Cited by 32
A Chemically Disrupted Proximity System for Controlling Dynamic Cellular Processes
Cunningham‐Bryant, D., Dieter, E. M., Foight, G., Rose, J. C., Loutey, D. E., & Maly, D. J. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b12382 · Cited by 29
Ege, N., Bouguenina, H., Tatari, M. N., & Chopra, R. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.011 · Cited by 31
Auxin-Inducible Degron System: An Efficient Protein Degradation Tool to Study Protein Function
Phanindhar, K., & Mishra, R. K. (2023) · BioTechniques · doi:10.2144/btn-2022-0108 · Cited by 30
Quantitatively Predictable Control of Cellular Protein Levels through Proteasomal Degradation
Zhao, W., Pferdehirt, L., & Segatori, L. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00325 · Cited by 28
Synthetic Biology: Immunotherapy by Design
Brenner, J., Cho, J. H., Wong, N. M. L., & Wong, W. W. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121147 · Cited by 26
Viganò, M., Ell, C.-M., Kustermann, M. M. M., Aguilar, G., Matsuda, S., Zhao, N., Stasevich, T. J., Pyrowolakis, G., & Affolter, M. (2021) · Development · doi:10.1242/dev.191700 · Cited by 24
Genetic circuits in synthetic biology: broadening the toolbox of regulatory devices
Müller, M. M., Arndt, K. M., & Hoffmann, S. A. (2025) · Frontiers in Synthetic Biology · doi:10.3389/fsybi.2025.1548572 · Cited by 32
Design of modular autoproteolytic gene switches responsive to anti-coronavirus drug candidates
Franko, N., Teixeira, A. P., Xue, S., Hamri, G. C., & Fussenegger, M. (2021) · Nature Communications · doi:10.1038/s41467-021-27072-3 · Cited by 26
Validating Small Molecule Chemical Probes for Biological Discovery
Vu, V., Szewczyk, M. M., Nie, D. Y., Arrowsmith, C. H., & Baršytė-Lovejoy, D. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-105344 · Cited by 26
Ma, X., Yin, J., Qiao, L., Wan, H., Liu, X., Zhou, Y., Wu, J., Niu, L., Wu, M., Wang, X., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.02.019 · Cited by 27
Synthetic macromolecular switches for precision control of therapeutic cell functions
Teixeira, A. P., & Fussenegger, M. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00235-9 · Cited by 28
Microhomology-based CRISPR tagging tools for protein tracking, purification, and depletion
Lin, D., Chung, B. P., Huang, J., Wang, X., Huang, L., & Kaiser, P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008422 · Cited by 22
Engineering stringent genetic biocontainment of yeast with a protein stability switch
Hoffmann, S. A., & Cai, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-44988-8 · Cited by 23
Small-molecule inducible transcriptional control in mammalian cells
Doshi, A., Sadeghi, F., Varadarajan, N., & Cirino, P. C. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1808583 · Cited by 23
Therapeutic roles of CAR T cells in infectious diseases: Clinical lessons learnt from cancer
Mohammadi, M., Akhoundi, M., Malih, S., Mohammadi, A., & Sheykhhasan, M. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2325 · Cited by 24
Development and Application of Functionalized Protein Binders in Multicellular Organisms
Bieli, D., Alborelli, I., Harmansa, S., Matsuda, S., Caussinus, E., & Affolter, M. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.02.006 · Cited by 23
Locus-Specific Knock-In of a Degradable Tag for Target Validation Studies
Brand, M., & Winter, G. E. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9145-7_7 · Cited by 21
Targeted protein degradation in mammalian cells: A promising avenue toward future
Zhang, T., Liu, C., Li, W., Kuang, J., Qiu, X., Lu, M., & Zhu, L. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.09.038 · Cited by 23
Domizi, P., Sarno, J., Jager, A., Merchant, M. J., Pacheco, K. Z., Yamada‐Hunter, S. A., Rotiroti, M. C., Liu, Y., Baskar, R., Reynolds, W. D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58868-2 · Cited by 21
Development of an AchillesTAG degradation system and its application to control CAR-T activity
Veits, G. K., Henderson, C. S., Vogelaar, A. L., Eron, S. J., Lee, L., Hart, A. A., Deibler, R. W., Baddour, J., Elam, W. A., Agafonov, R. V., et al. (2021) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2021.100010 · Cited by 22
Elango, R., Panday, A., Lach, F. P., Willis, N. A., Nicholson, K., Duffey, E. E., Smogorzewska, A., & Scully, R. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00812-9 · Cited by 21
Bacterial degrons in synthetic circuits
Jadhav, P., Chen, Y., Butzin, N. C., Buceta, J., & Urchueguía-Fornes, A. (2022) · Open Biology · doi:10.1098/rsob.220180 · Cited by 19
A small cassette enables conditional gene inactivation by CRISPR/Cas9
Guzzardo, P. M., Rashkova, C., dos Santos, R. L., Tehrani, R., Collin, P., & Bürckstümmer, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-16931-z · Cited by 21
Yenerall, P. M., Sung, T., Palyada, K., Qian, J., Arat, S., Kumpf, S. W., Wang, S., Biddle, K. E., Esparza, C., Chang, S., et al. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad049 · Cited by 18
Shiota, H., Alekseyenko, A. A., Wang, Z. A., Filic, I., Knox, T. M., Luong, N. M., Huang, Y., Scott, D. A., Jones, K. L., Gokhale, P. C., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0259 · Cited by 19
LncRNA SOX1‐OT V1 acts as a decoy of HDAC10 to promote SOX1‐dependent hESC neuronal differentiation
Xi, J., Xu, Y., Guo, Z., Li, J., Wu, Y., Sun, Q., Wang, Y., Chen, M., Zhu, S., Bian, S., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153015 · Cited by 20
Metadata
- Authors
- Chung, H. K., Jacobs, C. L., Huo, Y., Yang, J., Krumm, S. A., Plemper, R. K., Tsien, R. Y., & Lin, M. Z.
- Affiliations
- Stanford University (US)
- Stanford Medicine (US)
- University of California San Diego (US)
- Emory University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Lin, Michael Z
- Venue
- Nature Chemical Biology
- Published
- 2015-07-27
- Volume
- 11
- Issue
- 9
- Pages
- 713-720
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC4543534
- OpenAlex
- W1043004949
- Cited by
- 233
- References
- 56
- Citations by year
- 2026: 21 · 2025: 21 · 2024: 25 · 2023: 23 · 2022: 24 · 2021: 26 · 2020: 30 · 2019: 25 · 2018: 18 · 2017: 10 · 2016: 6 · 2015: 3
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM098734, P50GM107615)
- National Institute of Allergy and Infectious Diseases (R01AI071002, R01AI083402, R21AI119196)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD079327)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Keywords
- smash, protein degradation, HCV protease inhibitors, RNA viruses, yeast, mammalian cells
- MeSH terms
- Viral Proteases, Amino Acid Sequence, Animals, Bacterial Proteins, Binding Sites, Carrier Proteins, Chlorocebus aethiops, Gene Expression Regulation, HeLa Cells, Humans, Isoquinolines, Luminescent Proteins, Molecular Sequence Data, Neurons, Protease Inhibitors, Protein Binding, Recombinant Fusion Proteins, Serine Endopeptidases, Sulfonamides, Vero Cells, Hepacivirus, Rats, Sprague-Dawley, Viral Nonstructural Proteins, Nucleoside-Triphosphatase, Intracellular Signaling Peptides and Proteins, Rats, DEAD-box RNA Helicases, HEK293 Cells, Proteolysis, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
